Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07199920Not ApplicableNot Yet Recruiting

Implementation of New Multimodal MRI Sequences by Fingerprint to Improve Ischemic Stroke Examination.

Role: collaborator

NCT05385315Recruiting

Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease

Role: collaborator

NCT04182087Recruiting

Cognitive Function Assessment in Patients With Focal Brain Injury

Role: collaborator

NCT03940677Not ApplicableTerminated

Innovative Biomarkers in de Novo Parkinson's Disease

Role: collaborator

NCT04325971Not ApplicableCompleted

Study of Eye Movements as Markers of the Physiological, Cerebral and Cognitive State of Healthy Subjects

Role: collaborator

NCT01886131Not ApplicableTerminated

Motor Control During Rapid Eye Movement (REM) Sleep Behaviour Disorder

Role: collaborator

All 6 trials loaded